CD4 and HIV infectious disease: Mansue et al. [38] reported preclinical studies to account for the treatment of peripheral blood mononuclear cells with 1,25 (OH) 2D inhibits decreased cell susceptibility to HIV infection by inhibiting viral entry, modulating the expression of CD4+ cell surface antigens, damping viral p24 production, and limiting monocyte proliferation.